Adherence to lipid lowering drugs is associated with ldl-cholesterol goal achievement.

被引：0

作者：

Pladevall, M. ^{[1
]}

Williams, K. L. ^{[1
]}

Lafata, J. Elston ^{[1
]}

Tunceli, K. ^{[1
]}

Wang, M. ^{[1
]}

Campbell, I. ^{[1
]}

Divine, G. ^{[1
]}

Yang, J. ^{[1
]}

机构：

[1] Henry Ford Hlth Syst, Detroit, MI USA

来源：

AMERICAN JOURNAL OF EPIDEMIOLOGY | 2007年 / 165卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：S11 / S11

页数：1

共 50 条

[21] The final word about LDL-cholesterol lowering [J].

Streja, Dan .

CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2018, 25 (02) :101-102

[22] Time to LDL-cholesterol goal attainment in Spain [J].

Olivares, Q ;

Mabe, I ;

Nocea, G ;

Alemao, E ;

Caloto, T ;

Fosbrook, L ;

Ahumada, C ;

Yin, D .

VALUE IN HEALTH, 2004, 7 (06) :685-685

[23] Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter? [J].

Khan, Safi U. ;

Michos, Erin D. .

AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 1

[24] LDL-cholesterol goal attainment according to cardiovascular risk level in patients receiving lipid-lowering therapy in primary care [J].

Laforest, L. ;

Souchet, T. ;

Ritleng, C. ;

Desamericq, G. ;

Kieffer, A. ;

Le Jeunne, P. ;

Van Ganse, E. .

EUROPEAN HEART JOURNAL, 2007, 28 :601-601

[25] Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada [J].

Gitt, Anselm K. ;

Drexel, Heinz ;

Feely, John ;

Ferrieres, Jean ;

Gonzalez-Juanatey, Jose R. ;

Thomsen, Kristian K. ;

Leiter, Lawrence A. ;

Lundman, Pia ;

da Silva, Pedro M. ;

Pedersen, Terje ;

Wood, David ;

Juenger, Claus ;

Dellea, Pam S. ;

Sazonov, Vasilisa ;

Chazelle, Francois ;

Kastelein, John J. P. .

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (02) :221-230

[26] Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital [J].

Sangsawang, Tamon ;

Sriwijitkamol, Apiradee .

VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 :563-567

[27] Lowering of LDL-cholesterol may increase risk of cancer [J].

Reactions Weekly, 2007, 1164 (1) :2-2

[28] Intensive LDL-cholesterol lowering therapy and neurocognitive function [J].

Banach, Maciej ;

Rizzo, Manfredi ;

Nikolic, Dragana ;

Howard, George ;

Howard, VirginiaJ. ;

Mikhailidis, DimitriP. .

PHARMACOLOGY & THERAPEUTICS, 2017, 170 :181-191

[29] Predictors of LDL-cholesterol goal achievement in secondary prevention in Europe and Canada: results of the Dyslipidemia International Study [J].

Gitt, A. K. ;

Juenger, C. ;

Smolka, W. ;

Bestehorn, K. ;

Lundman, P. ;

Leiter, L. ;

Pedersen, T. ;

Gonzalez-Juanatey, J. ;

Chazelle, F. ;

Kastelein, J. .

EUROPEAN HEART JOURNAL, 2010, 31 :373-373

[30] Molecular pathways and agents for lowering LDL-cholesterol in addition to statins [J].

Costet, Philippe .

PHARMACOLOGY & THERAPEUTICS, 2010, 126 (03) :263-278

← 1 2 3 4 5 →